StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Biohit Oyj
Helsinki Stock Exchange:BIOBV.HE
Sector
Location
Market Cap
USD 53.25 M
Share Price
USD 3.51
Avg Daily Volume
11,028
Change (1 day)
-3.01%
Change (1 year)
55.87%
Change (YTD)
47.14%
Biohit Oyj EBITDA for the year ending December 31, 2024: USD 3.63 M
Biohit Oyj EBITDA is USD 3.63 M for the year ending December 31, 2024, a 70.06% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
-
Biohit Oyj EBITDA for the year ending December 31, 2023 was USD 2.13 M, a 48.59% change year over year.
-
Biohit Oyj EBITDA for the year ending December 31, 2022 was USD 1.44 M, a 82.28% change year over year.
-
Biohit Oyj EBITDA for the year ending December 31, 2021 was USD 787.74 K, a -151.55% change year over year.
-
Biohit Oyj EBITDA for the year ending December 31, 2020 was USD -1.53 M, a -274.81% change year over year.
Competitors
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
Thermo Fisher Scientific Inc.
USD 434.86
TMO
+4.13
0.96%
Boston Scientific Corporation
USD 103.20
BSX
-0.66
-0.64%
Siemens Healthineers AG
USD 53.86
SHL.DE
-2.12
-3.79%
Becton, Dickinson and Company
USD 175.97
BDX
-1.53
-0.86%
Agilent Technologies, Inc.
USD 123.28
A
-0.89
-0.72%
GE HealthCare Technologies Inc.
USD 75.13
GEHC
-1.37
-1.79%
Natera, Inc.
USD 160.43
NTRA
-2.93
-1.79%
Laboratory Corporation of America Holdings
USD 249.62
LH
-4.01
-1.58%
bioMérieux S.A.
USD 139.44
BIM.PA
-2.83
-1.99%
Baxter International Inc.
USD 28.70
BAX
-1.00
-3.37%
Revvity, Inc.
USD 101.50
RVTY
-0.90
-0.88%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.30
603392.SS
-0.05
-0.62%
Tempus AI, Inc.
USD 56.88
TEM
-2.72
-4.56%
Qiagen N.V.
USD 48.13
QGEN
-0.42
-0.86%
Exact Sciences Corporation
USD 51.91
EXAS
-1.41
-2.64%
Globus Medical, Inc.
USD 57.12
GMED
-0.68
-1.18%
ConvaTec Group Plc
USD 3.52
CTEC.L
-0.07
-1.87%
Hangzhou Tigermed Consulting Co., Ltd.
USD 6.38
3347.HK
+0.24
3.94%
Key Data
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
Competitors
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
Thermo Fisher Scientific Inc.
USD 434.86
TMO
+4.13
0.96%
Boston Scientific Corporation
USD 103.20
BSX
-0.66
-0.64%
Siemens Healthineers AG
USD 53.86
SHL.DE
-2.12
-3.79%
Becton, Dickinson and Company
USD 175.97
BDX
-1.53
-0.86%
Agilent Technologies, Inc.
USD 123.28
A
-0.89
-0.72%
GE HealthCare Technologies Inc.
USD 75.13
GEHC
-1.37
-1.79%
Natera, Inc.
USD 160.43
NTRA
-2.93
-1.79%
Laboratory Corporation of America Holdings
USD 249.62
LH
-4.01
-1.58%
bioMérieux S.A.
USD 139.44
BIM.PA
-2.83
-1.99%
Baxter International Inc.
USD 28.70
BAX
-1.00
-3.37%
Revvity, Inc.
USD 101.50
RVTY
-0.90
-0.88%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.30
603392.SS
-0.05
-0.62%
Tempus AI, Inc.
USD 56.88
TEM
-2.72
-4.56%
Qiagen N.V.
USD 48.13
QGEN
-0.42
-0.86%
Exact Sciences Corporation
USD 51.91
EXAS
-1.41
-2.64%
Globus Medical, Inc.
USD 57.12
GMED
-0.68
-1.18%
ConvaTec Group Plc
USD 3.52
CTEC.L
-0.07
-1.87%
Hangzhou Tigermed Consulting Co., Ltd.
USD 6.38
3347.HK
+0.24
3.94%